J Amp News Today

A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.

Courts have rebuffed J&J’s two previous efforts to resolve the lawsuits through the bankruptcy of the subsidiary created to absorb J&J’s talc liability, LTL Management

31-year-old JJ Hanrahan feels at home with Connacht after several stints abroad.

Nigeria's health regulator is recalling a batch of Johnson & Johnson children's cough syrup after finding an unacceptably high level of a potentially fatal toxic substance, it said on Wednesday.

Johnson & Johnson to buy Shockwave Medical for $12.5B, expanding heart device portfolio. Deal, J&Js largest since Abiomed acquisition, includes shockwave tech for heart diseases. Deal expected to close mid-2024.

The acquisition gives Johnson & Johnson access to a device that uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated

"Consistent with the plan we outlined last year, the company continues to pursue several paths to achieve a comprehensive and final resolution of the talc litigation," Erik Haas, J&Js worldwide vice president of litigation, said in a statement.

Explore Johnson & Johnson's strategic move toward a $700M talc settlement with 42 states, addressing legal battles and reaffirming product safety amidst over 50,000 lawsuits.

J&J is agreeing to a tentative deal to settle investigations by more than 40 states in connection with the safety of its baby powder

The Washington state attorney general has announced a $149.5 million settlement agreement with drugmaker Johnson & Johnson.